Clinical Trial Update: Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating the effect of molsidomine on endothelial dysfunction in patients with stable angina pectoris; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Stable Angina Pectoris

Drugs mentioned

• Molsidomine (molsidomine)

Snippet

Sponsor: Therabel Pharma SA/NV | Conditions: Stable Angina Pectoris, Atherosclerosis | Phase 4 | Status: COMPLETED | Results posted: 2014-09-26